-Tehelka By brazening it out against graft allegations, our netas are mocking common decencies. IT IS extremely unlikely that India Against Corruption, or the political arm it has promised, will win too many votes or even a single seat in the 2014 Lok Sabha election. It goes without saying though that at the current juncture, it is winning a perception and media battle against the political class. Each time a politician is...
More »SEARCH RESULT
Drivers are directors in netas’ firms -Prafulla Marapakwar
-The Times of India MUMBAI: Manohar Panse, the driver of BJP president Nitin Gadkari, who was found to be a director on several of Gadkari's companies, is not alone. Peons, clerks and drivers of leading politicians have become overnight millionaires or secured key assignments in the institutions set up by their employers. TOI was the first to break the story about Panse being a director in five of Gadkari's Purti Power and...
More »Joseph E Stiglitz, Nobel laureate interviewed by Pranay Sharma
-Outlook Nobel laureate Joseph E. Stiglitz is one of the world’s leading economists. A former chief economist at the World Bank and currently University Professor at the Columbia Business School, he was recently in India to attend an international conference on development and to promote his new book, The Price of Inequality. He spoke to Pranay Sharma about growing inequality in the world and the challenges facing India. Excerpts: * Your coinage,...
More »Where the jobs are-Rajeev Dehejia
-The Indian Express The International Monetary Fund’s recent downgrading of the growth forecast for India from 6.2 per cent to 4.9 per cent for 2012, which came on the heels of the decline in the actual growth rate to below 5.5 per cent in the first half of 2012, has brought reforms back to the centrestage of the policy discourse. Which reforms are needed and why? India’s growth trajectory has been unique....
More »Health ministry pushes for end to sale of branded drugs -Kounteya Sinha
-The Times of India Medicines in India may not be sold under brand names in the near future. In its biggest move to push generic drugs and do away with brand names, the Union health ministry has ordered states to stop issuing licence for the manufacture or sale of drugs on the basis of their brand name. All pharmaceutical firms applying for licence to market or manufacture fixed dose combination (FDC) drugs will...
More »